About the treatment
Lipidapheresis and H.E.L.P. Apheresis are highly targeted extracorporeal therapies that remove atherogenic lipoproteins—such as LDL cholesterol, lipoprotein(a), and other lipid fractions—along with inflammatory mediators and microclots directly from the bloodstream. Through advanced filtration and adsorption systems, these techniques enable a rapid and precise reduction of pathogenic lipids and inflammatory factors, supporting improved rheology, endothelial function, and microcirculation.
By directly addressing key drivers of vascular dysfunction and systemic inflammation, lipid and H.E.L.P. apheresis contribute to cardiovascular risk reduction and systemic optimization. Integrated into personalized treatment strategies, they are particularly valuable in patients with elevated lipid burden, vascular inflammation, or complex metabolic profiles, supporting long-term vascular integrity and performance.
Treatments
